{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:09:05Z","timestamp":1787069345101,"version":"build-2736575974"},"reference-count":131,"publisher":"Springer Science and Business Media LLC","issue":"7-8","license":[{"start":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T00:00:00Z","timestamp":1749427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T00:00:00Z","timestamp":1749427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Social Development Special Fund of Yunnan Province Science and Technology Department","award":["202403AC100017"],"award-info":[{"award-number":["202403AC100017"]}]},{"name":"Project of Xi'an Municipal Health Commission","award":["grant no. 2024ms03"],"award-info":[{"award-number":["grant no. 2024ms03"]}]},{"name":"Innovation Capability Support Plan-Medical Research Project of Xi\u2019an Science and Technology Bureau","award":["grant no. 23YXYJ0001"],"award-info":[{"award-number":["grant no. 23YXYJ0001"]}]},{"name":"Key Research and Development Project of the Tibet Autonomous Region","award":["grant no. XZ202501ZY0044"],"award-info":[{"award-number":["grant no. XZ202501ZY0044"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Apoptosis"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s10495-025-02130-z","type":"journal-article","created":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T04:31:30Z","timestamp":1749443490000},"page":"1776-1795","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Ferroptosis: a novel therapeutic warrior in the battle against leukemia"],"prefix":"10.1007","volume":"30","author":[{"given":"Yiduo","family":"Bai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyi","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junchang","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruijing","family":"Ping","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiuru","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuxu","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyan","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,9]]},"reference":[{"key":"2130_CR1","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1007\/s00277-022-04843-6","volume":"101","author":"R Sharma","year":"2022","unstructured":"Sharma R, Jani C (2022) Mapping incidence and mortality of leukemia and its subtypes in 21 world regions in last three decades and projections to 2030. Ann Hematol 101:1523\u20131534. https:\/\/doi.org\/10.1007\/s00277-022-04843-6","journal-title":"Ann Hematol"},{"key":"2130_CR2","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41568-021-00355-z","volume":"21","author":"AE Whiteley","year":"2021","unstructured":"Whiteley AE, Price TT, Cantelli G, Sipkins DA (2021) Leukaemia: a model metastatic disease. Nat Rev Cancer 21:461\u2013475. https:\/\/doi.org\/10.1038\/s41568-021-00355-z","journal-title":"Nat Rev Cancer"},{"key":"2130_CR3","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","volume":"129","author":"H D\u00f6hner","year":"2017","unstructured":"D\u00f6hner H, Estey E, Grimwade D et al (2017) Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood 129:424\u2013447. https:\/\/doi.org\/10.1182\/blood-2016-08-733196","journal-title":"Blood"},{"key":"2130_CR4","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41586-020-2864-x","volume":"587","author":"LA Miles","year":"2020","unstructured":"Miles LA, Bowman RL, Merlinsky TR et al (2020) Single-cell mutation analysis of clonal evolution in myeloid malignancies. Nature 587:477\u2013482. https:\/\/doi.org\/10.1038\/s41586-020-2864-x","journal-title":"Nature"},{"key":"2130_CR5","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.3324\/haematol.2020.247031","volume":"105","author":"H Inaba","year":"2020","unstructured":"Inaba H, Mullighan CG (2020) Pediatric acute lymphoblastic leukemia. Haematologica 105:2524\u20132539. https:\/\/doi.org\/10.3324\/haematol.2020.247031","journal-title":"Haematologica"},{"key":"2130_CR6","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1182\/blood-2013-05-501569","volume":"122","author":"M Baccarani","year":"2013","unstructured":"Baccarani M, Deininger MW, Rosti G et al (2013) European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013. Blood 122:872\u2013884. https:\/\/doi.org\/10.1182\/blood-2013-05-501569","journal-title":"Blood"},{"key":"2130_CR7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.annonc.2020.09.019","volume":"32","author":"B Eichhorst","year":"2021","unstructured":"Eichhorst B, Robak T, Montserrat E et al (2021) Chronic lymphocytic leukaemia: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol Off J Eur Soc Med Oncol 32:23\u201333. https:\/\/doi.org\/10.1016\/j.annonc.2020.09.019","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"2130_CR8","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR et al (2012) Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149:1060\u20131072. https:\/\/doi.org\/10.1016\/j.cell.2012.03.042","journal-title":"Cell"},{"key":"2130_CR9","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","volume":"171","author":"BR Stockwell","year":"2017","unstructured":"Stockwell BR, Friedmann Angeli JP, Bayir H et al (2017) Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell 171:273\u2013285. https:\/\/doi.org\/10.1016\/j.cell.2017.09.021","journal-title":"Cell"},{"key":"2130_CR10","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1097\/cm9.0000000000002239","volume":"136","author":"L Gong","year":"2023","unstructured":"Gong L, Huang D, Shi Y, Liang Z, Bu H (2023) Regulated cell death in cancer: from pathogenesis to treatment. Chin Med J 136:653\u2013665. https:\/\/doi.org\/10.1097\/cm9.0000000000002239","journal-title":"Chin Med J"},{"key":"2130_CR11","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang X, Stockwell BR, Conrad M (2021) Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol 22:266\u2013282. https:\/\/doi.org\/10.1038\/s41580-020-00324-8","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2130_CR12","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","volume":"156","author":"WS Yang","year":"2014","unstructured":"Yang WS, SriRamaratnam R, Welsch ME et al (2014) Regulation of ferroptotic cancer cell death by GPX4. Cell 156:317\u2013331. https:\/\/doi.org\/10.1016\/j.cell.2013.12.010","journal-title":"Cell"},{"key":"2130_CR13","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41420-021-00579-w","volume":"7","author":"Y Yu","year":"2021","unstructured":"Yu Y, Yan Y, Niu F et al (2021) Ferroptosis: a cell death connecting oxidative stress, inflammation and cardiovascular diseases. Cell Death Discov 7:193. https:\/\/doi.org\/10.1038\/s41420-021-00579-w","journal-title":"Cell Death Discov"},{"key":"2130_CR14","doi-asserted-by":"publisher","first-page":"586530","DOI":"10.3389\/fonc.2020.586530","volume":"10","author":"E Grignano","year":"2020","unstructured":"Grignano E, Birsen R, Chapuis N, Bouscary D (2020) From Iron chelation to overload as a therapeutic strategy to induce ferroptosis in leukemic cells. Front Oncol 10:586530. https:\/\/doi.org\/10.3389\/fonc.2020.586530","journal-title":"Front Oncol"},{"key":"2130_CR15","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3892\/ol.2024.14470","volume":"28","author":"N Tang","year":"2024","unstructured":"Tang N, Liu X, Liu Y et al (2024) Dihydroartemisinin induces ferroptosis in T cell acute lymphoblastic leukemia cells by downregulating SLC7A11 and activating the ATF4\u2013CHOP signaling pathway. Oncol Lett 28:337. https:\/\/doi.org\/10.3892\/ol.2024.14470","journal-title":"Oncol Lett"},{"key":"2130_CR16","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1089\/dna.2021.1145","volume":"41","author":"X Zhang","year":"2022","unstructured":"Zhang X, Ai Z, Zhang Z et al (2022) Dihydroartemisinin triggers ferroptosis in multidrug-resistant leukemia cells. DNA Cell Biol 41:705\u2013715. https:\/\/doi.org\/10.1089\/dna.2021.1145","journal-title":"DNA Cell Biol"},{"key":"2130_CR17","doi-asserted-by":"publisher","first-page":"910292","DOI":"10.3389\/fphar.2022.910292","volume":"13","author":"FJ Li","year":"2022","unstructured":"Li FJ, Long HZ, Zhou ZW, Luo HY, Xu SG, Gao LC (2022) System X(c) (-)\/GSH\/GPX4 axis: an important antioxidant system for the ferroptosis in drug-resistant solid tumor therapy. Front Pharmacol 13:910292. https:\/\/doi.org\/10.3389\/fphar.2022.910292","journal-title":"Front Pharmacol"},{"key":"2130_CR18","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1186\/s13046-019-1397-3","volume":"38","author":"F Wang","year":"2019","unstructured":"Wang F, Lv H, Zhao B et al (2019) Iron and leukemia: new insights for future treatments. J Exp Clin Cancer Res CR 38:406. https:\/\/doi.org\/10.1186\/s13046-019-1397-3","journal-title":"J Exp Clin Cancer Res CR"},{"key":"2130_CR19","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.tcb.2023.10.001","volume":"34","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Chen C, Li X, Zheng J, Zhao Y (2024) Regulation of leukemogenesis via redox metabolism. Trends Cell Biol 34:928\u2013941. https:\/\/doi.org\/10.1016\/j.tcb.2023.10.001","journal-title":"Trends Cell Biol"},{"key":"2130_CR20","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.canlet.2020.02.015","volume":"483","author":"Y Su","year":"2020","unstructured":"Su Y, Zhao B, Zhou L et al (2020) Ferroptosis, a novel pharmacological mechanism of anti-cancer drugs. Cancer Lett 483:127\u2013136. https:\/\/doi.org\/10.1016\/j.canlet.2020.02.015","journal-title":"Cancer Lett"},{"key":"2130_CR21","doi-asserted-by":"publisher","first-page":"743006","DOI":"10.3389\/fonc.2021.743006","volume":"11","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, Huang Z, Peng H (2021) Molecular mechanisms of ferroptosis and its roles in hematologic malignancies. Front Oncol 11:743006. https:\/\/doi.org\/10.3389\/fonc.2021.743006","journal-title":"Front Oncol"},{"key":"2130_CR22","doi-asserted-by":"publisher","first-page":"e1800311","DOI":"10.1002\/pmic.201800311","volume":"19","author":"GC Forcina","year":"2019","unstructured":"Forcina GC, Dixon SJ (2019) GPX4 at the crossroads of lipid homeostasis and ferroptosis. Proteomics 19:e1800311. https:\/\/doi.org\/10.1002\/pmic.201800311","journal-title":"Proteomics"},{"key":"2130_CR23","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.freeradbiomed.2018.12.011","volume":"131","author":"J Du","year":"2019","unstructured":"Du J, Wang T, Li Y et al (2019) DHA inhibits proliferation and induces ferroptosis of leukemia cells through autophagy dependent degradation of ferritin. Free Radic Biol Med 131:356\u2013369. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2018.12.011","journal-title":"Free Radic Biol Med"},{"key":"2130_CR24","doi-asserted-by":"publisher","first-page":"403","DOI":"10.3324\/haematol.2020.259531","volume":"107","author":"R Birsen","year":"2022","unstructured":"Birsen R, Larrue C, Decroocq J et al (2022) APR-246 induces early cell death by ferroptosis in acute myeloid leukemia. Haematologica 107:403\u2013416. https:\/\/doi.org\/10.3324\/haematol.2020.259531","journal-title":"Haematologica"},{"key":"2130_CR25","doi-asserted-by":"publisher","first-page":"e1054549","DOI":"10.1080\/23723556.2015.1054549","volume":"2","author":"Y Yu","year":"2015","unstructured":"Yu Y, Xie Y, Cao L et al (2015) The ferroptosis inducer erastin enhances sensitivity of acute myeloid leukemia cells to chemotherapeutic agents. Mol Cell Oncol 2:e1054549. https:\/\/doi.org\/10.1080\/23723556.2015.1054549","journal-title":"Mol Cell Oncol"},{"key":"2130_CR26","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1016\/j.bbagen.2017.05.019","volume":"1861","author":"GO Latunde-Dada","year":"2017","unstructured":"Latunde-Dada GO (2017) Ferroptosis: role of lipid peroxidation, iron and ferritinophagy. Biochim Biophys Acta Gen Subj 1861:1893\u20131900. https:\/\/doi.org\/10.1016\/j.bbagen.2017.05.019","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"2130_CR27","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1111\/jcmm.13008","volume":"21","author":"H Yu","year":"2017","unstructured":"Yu H, Guo P, Xie X, Wang Y, Chen G (2017) Ferroptosis, a new form of cell death, and its relationships with tumourous diseases. J Cell Mol Med 21:648\u2013657. https:\/\/doi.org\/10.1111\/jcmm.13008","journal-title":"J Cell Mol Med"},{"key":"2130_CR28","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","volume":"31","author":"D Tang","year":"2021","unstructured":"Tang D, Chen X, Kang R, Kroemer G (2021) Ferroptosis: molecular mechanisms and health implications. Cell Res 31:107\u2013125. https:\/\/doi.org\/10.1038\/s41422-020-00441-1","journal-title":"Cell Res"},{"key":"2130_CR29","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.freeradbiomed.2017.08.008","volume":"112","author":"D Giustarini","year":"2017","unstructured":"Giustarini D, Colombo G, Garavaglia ML et al (2017) Assessment of glutathione\/glutathione disulphide ratio and S-glutathionylated proteins in human blood, solid tissues, and cultured cells. Free Radic Biol Med 112:360\u2013375. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2017.08.008","journal-title":"Free Radic Biol Med"},{"key":"2130_CR30","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s41416-022-01998-x","volume":"128","author":"A Ajoolabady","year":"2023","unstructured":"Ajoolabady A, Tang D, Kroemer G, Ren J (2023) Ferroptosis in hepatocellular carcinoma: mechanisms and targeted therapy. Br J Cancer 128:190\u2013205. https:\/\/doi.org\/10.1038\/s41416-022-01998-x","journal-title":"Br J Cancer"},{"key":"2130_CR31","doi-asserted-by":"publisher","first-page":"2915019","DOI":"10.1155\/2021\/2915019","volume":"2021","author":"S Li","year":"2021","unstructured":"Li S, He Y, Chen K et al (2021) RSL3 drives ferroptosis through NF-\u03baB pathway activation and GPX4 depletion in glioblastoma. Oxid Med Cell Longev 2021:2915019. https:\/\/doi.org\/10.1155\/2021\/2915019","journal-title":"Oxid Med Cell Longev"},{"key":"2130_CR32","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/s0891-5849(02)01006-7","volume":"33","author":"O Kakhlon","year":"2002","unstructured":"Kakhlon O, Cabantchik ZI (2002) The labile iron pool: characterization, measurement, and participation in cellular processes(1). Free Radic Biol Med 33:1037\u20131046. https:\/\/doi.org\/10.1016\/s0891-5849(02)01006-7","journal-title":"Free Radic Biol Med"},{"key":"2130_CR33","doi-asserted-by":"publisher","first-page":"590226","DOI":"10.3389\/fcell.2020.590226","volume":"8","author":"X Chen","year":"2020","unstructured":"Chen X, Yu C, Kang R, Tang D (2020) Iron metabolism in ferroptosis. Front Cell Dev Biol 8:590226. https:\/\/doi.org\/10.3389\/fcell.2020.590226","journal-title":"Front Cell Dev Biol"},{"key":"2130_CR34","doi-asserted-by":"publisher","first-page":"5405","DOI":"10.3892\/ol.2018.8066","volume":"15","author":"S Hao","year":"2018","unstructured":"Hao S, Liang B, Huang Q et al (2018) Metabolic networks in ferroptosis. Oncol Lett 15:5405\u20135411. https:\/\/doi.org\/10.3892\/ol.2018.8066","journal-title":"Oncol Lett"},{"key":"2130_CR35","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","volume":"575","author":"K Bersuker","year":"2019","unstructured":"Bersuker K, Hendricks JM, Li Z et al (2019) The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature 575:688\u2013692. https:\/\/doi.org\/10.1038\/s41586-019-1705-2","journal-title":"Nature"},{"key":"2130_CR36","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1152\/physrev.00031.2024","volume":"105","author":"J Zheng","year":"2025","unstructured":"Zheng J, Conrad M (2025) Ferroptosis: when metabolism Meets cell death. Physiol Rev 105:651\u2013706. https:\/\/doi.org\/10.1152\/physrev.00031.2024","journal-title":"Physiol Rev"},{"key":"2130_CR37","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/nchembio.2079","volume":"12","author":"K Shimada","year":"2016","unstructured":"Shimada K, Skouta R, Kaplan A et al (2016) Global survey of cell death mechanisms reveals metabolic regulation of ferroptosis. Nat Chem Biol 12:497\u2013503. https:\/\/doi.org\/10.1038\/nchembio.2079","journal-title":"Nat Chem Biol"},{"key":"2130_CR38","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/s41419-024-06584-y","volume":"15","author":"L Ye","year":"2024","unstructured":"Ye L, Wen X, Qin J et al (2024) Metabolism-regulated ferroptosis in cancer progression and therapy. Cell Death Dis 15:196. https:\/\/doi.org\/10.1038\/s41419-024-06584-y","journal-title":"Cell Death Dis"},{"key":"2130_CR39","doi-asserted-by":"publisher","first-page":"1308869","DOI":"10.3389\/fonc.2023.1308869","volume":"13","author":"Z Chen","year":"2023","unstructured":"Chen Z, Zheng S, Han J et al (2023) Molecular mechanisms of ferroptosis and its roles in leukemia. Front Oncol 13:1308869. https:\/\/doi.org\/10.3389\/fonc.2023.1308869","journal-title":"Front Oncol"},{"key":"2130_CR40","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/s41419-023-06045-y","volume":"14","author":"Y Liu","year":"2023","unstructured":"Liu Y, Lu S, Wu LL, Yang L, Yang L, Wang J (2023) The diversified role of mitochondria in ferroptosis in cancer. Cell Death Dis 14:519. https:\/\/doi.org\/10.1038\/s41419-023-06045-y","journal-title":"Cell Death Dis"},{"key":"2130_CR41","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41586-021-03539-7","volume":"593","author":"C Mao","year":"2021","unstructured":"Mao C, Liu X, Zhang Y et al (2021) DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer. Nature 593:586\u2013590. https:\/\/doi.org\/10.1038\/s41586-021-03539-7","journal-title":"Nature"},{"key":"2130_CR42","doi-asserted-by":"publisher","first-page":"165759","DOI":"10.1016\/j.bbadis.2020.165759","volume":"1866","author":"S Boukalova","year":"2020","unstructured":"Boukalova S, Hubackova S, Milosevic M, Ezrova Z, Neuzil J, Rohlena J (2020) Dihydroorotate dehydrogenase in oxidative phosphorylation and cancer. Biochim Biophys Acta Mol Basis Dis 1866:165759. https:\/\/doi.org\/10.1016\/j.bbadis.2020.165759","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"2130_CR43","doi-asserted-by":"publisher","first-page":"101619","DOI":"10.1016\/j.redox.2020.101619","volume":"36","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Guo M, Shen M et al (2020) The BRD7-P53-SLC25A28 axis regulates ferroptosis in hepatic stellate cells. Redox Biol 36:101619. https:\/\/doi.org\/10.1016\/j.redox.2020.101619","journal-title":"Redox Biol"},{"key":"2130_CR44","doi-asserted-by":"publisher","first-page":"627662","DOI":"10.3389\/fimmu.2020.627662","volume":"11","author":"S Weber","year":"2020","unstructured":"Weber S, Parmon A, Kurrle N, Schn\u00fctgen F, Serve H (2020) The clinical significance of Iron overload and Iron metabolism in myelodysplastic syndrome and acute myeloid leukemia. Front Immunol 11:627662. https:\/\/doi.org\/10.3389\/fimmu.2020.627662","journal-title":"Front Immunol"},{"key":"2130_CR45","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41419-020-2298-2","volume":"11","author":"J Li","year":"2020","unstructured":"Li J, Cao F, Yin HL et al (2020) Ferroptosis: past, present and future. Cell Death Dis 11:88. https:\/\/doi.org\/10.1038\/s41419-020-2298-2","journal-title":"Cell Death Dis"},{"key":"2130_CR46","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1182\/blood-2011-12-399667","volume":"120","author":"M Roth","year":"2012","unstructured":"Roth M, Will B, Simkin G et al (2012) Eltrombopag inhibits the proliferation of leukemia cells via reduction of intracellular iron and induction of differentiation. Blood 120:386\u2013394. https:\/\/doi.org\/10.1182\/blood-2011-12-399667","journal-title":"Blood"},{"key":"2130_CR47","doi-asserted-by":"publisher","first-page":"3064","DOI":"10.1182\/blood-2009-03-209965","volume":"114","author":"Y Eberhard","year":"2009","unstructured":"Eberhard Y, McDermott SP, Wang X et al (2009) Chelation of intracellular iron with the antifungal agent ciclopirox olamine induces cell death in leukemia and myeloma cells. Blood 114:3064\u20133073. https:\/\/doi.org\/10.1182\/blood-2009-03-209965","journal-title":"Blood"},{"key":"2130_CR48","doi-asserted-by":"publisher","first-page":"101479","DOI":"10.1016\/j.rineng.2023.101479","volume":"20","author":"MH Ashoub","year":"2023","unstructured":"Ashoub MH, Amiri M, Razavi R et al (2023) Induction of ferroptosis cell death in acute promyelocytic leukemia cell lines (NB4 and HL-60) using hydrothermally synthesized ZnO NPs in the presence of black cardamom extract. Results Eng 20:101479. https:\/\/doi.org\/10.1016\/j.rineng.2023.101479","journal-title":"Results Eng"},{"key":"2130_CR49","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41420-023-01371-8","volume":"9","author":"E Grignano","year":"2023","unstructured":"Grignano E, Cantero-Aguilar L, Tuerdi Z et al (2023) Dihydroartemisinin-induced ferroptosis in acute myeloid leukemia: links to iron metabolism and metallothionein. Cell Death Discov 9:97. https:\/\/doi.org\/10.1038\/s41420-023-01371-8","journal-title":"Cell Death Discov"},{"key":"2130_CR50","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41420-024-01800-2","volume":"10","author":"X Yu","year":"2024","unstructured":"Yu X, Wang Y, Tan J et al (2024) Inhibition of NRF2 enhances the acute myeloid leukemia cell death induced by venetoclax via the ferroptosis pathway. Cell Death Discov 10:35. https:\/\/doi.org\/10.1038\/s41420-024-01800-2","journal-title":"Cell Death Discov"},{"key":"2130_CR51","doi-asserted-by":"publisher","first-page":"63779","DOI":"10.18632\/oncotarget.11687","volume":"7","author":"J D\u00e4chert","year":"2016","unstructured":"D\u00e4chert J, Schoeneberger H, Rohde K, Fulda S (2016) RSL3 and erastin differentially regulate redox signaling to promote Smac mimetic-induced cell death. Oncotarget 7:63779\u201363792. https:\/\/doi.org\/10.18632\/oncotarget.11687","journal-title":"Oncotarget"},{"key":"2130_CR52","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1159\/000227440","volume":"52","author":"S Paydas","year":"1995","unstructured":"Paydas S, Yuregir GT, Sahin B, Seyrek E, Burgut R (1995) Intracellular glutathione content in leukemias. Oncology 52:112\u2013115. https:\/\/doi.org\/10.1159\/000227440","journal-title":"Oncology"},{"key":"2130_CR53","doi-asserted-by":"publisher","first-page":"13486","DOI":"10.18632\/aging.205257","volume":"15","author":"Z Ma","year":"2023","unstructured":"Ma Z, Ye W, Huang X et al (2023) The ferroptosis landscape in acute myeloid leukemia. Aging 15:13486\u201313503. https:\/\/doi.org\/10.18632\/aging.205257","journal-title":"Aging"},{"key":"2130_CR54","doi-asserted-by":"publisher","first-page":"678","DOI":"10.21037\/atm-20-3296","volume":"8","author":"J Wei","year":"2020","unstructured":"Wei J, Xie Q, Liu X et al (2020) Identification the prognostic value of glutathione peroxidases expression levels in acute myeloid leukemia. Ann Transl Med 8:678. https:\/\/doi.org\/10.21037\/atm-20-3296","journal-title":"Ann Transl Med"},{"key":"2130_CR55","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s40164-023-00411-4","volume":"12","author":"X Liu","year":"2023","unstructured":"Liu X, Zhong S, Qiu K et al (2023) Targeting NRF2 uncovered an intrinsic susceptibility of acute myeloid leukemia cells to ferroptosis. Exp Hematol Oncol 12:47. https:\/\/doi.org\/10.1186\/s40164-023-00411-4","journal-title":"Exp Hematol Oncol"},{"key":"2130_CR56","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1177\/15353702211004870","volume":"246","author":"S Lou","year":"2021","unstructured":"Lou S, Hong H, Maihesuti L et al (2021) Inhibitory effect of hydnocarpin D on T-cell acute lymphoblastic leukemia via induction of autophagy-dependent ferroptosis. Exp Biol Med (Maywood NJ) 246:1541\u20131553. https:\/\/doi.org\/10.1177\/15353702211004870","journal-title":"Exp Biol Med (Maywood NJ)"},{"key":"2130_CR57","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1182\/blood-2020-142735","volume":"136","author":"J Xia","year":"2020","unstructured":"Xia J, Sun S, Jotte MRM et al (2020) Combined Inhibition of CXCR4 signaling and system xc- transporter activity induces synthetic lethality in T-ALL cells by suppressing Gsh and inducing ferroptosis. Blood 136:37. https:\/\/doi.org\/10.1182\/blood-2020-142735","journal-title":"Blood"},{"key":"2130_CR58","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.bbrc.2022.03.105","volume":"608","author":"L Chen","year":"2022","unstructured":"Chen L, Fang W, Liu J et al (2022) Poricoic acid A (PAA) inhibits T-cell acute lymphoblastic leukemia through inducing autophagic cell death and ferroptosis. Biochem Biophys Res Commun 608:108\u2013115. https:\/\/doi.org\/10.1016\/j.bbrc.2022.03.105","journal-title":"Biochem Biophys Res Commun"},{"key":"2130_CR59","doi-asserted-by":"publisher","first-page":"102408","DOI":"10.1016\/j.redox.2022.102408","volume":"55","author":"LB Pontel","year":"2022","unstructured":"Pontel LB, Bueno-Costa A, Morellato AE, Carvalho Santos J, Rou\u00e9 G, Esteller M (2022) Acute lymphoblastic leukemia necessitates GSH-dependent ferroptosis defenses to overcome FSP1-epigenetic silencing. Redox Biol 55:102408. https:\/\/doi.org\/10.1016\/j.redox.2022.102408","journal-title":"Redox Biol"},{"key":"2130_CR60","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1177\/10815589241246541","volume":"72","author":"J Li","year":"2024","unstructured":"Li J, Ma J, Zhang R, Zhai Y, Zhang W, Fu R (2024) A new therapeutic perspective: Erastin inhibits tumor progression by driving ferroptosis in myelodysplastic syndromes. J Invest Med Off Publ Am Fed Clin Res 72:414\u2013424. https:\/\/doi.org\/10.1177\/10815589241246541","journal-title":"J Invest Med Off Publ Am Fed Clin Res"},{"key":"2130_CR61","doi-asserted-by":"publisher","first-page":"7674565","DOI":"10.1155\/2021\/7674565","volume":"2021","author":"S Liu","year":"2021","unstructured":"Liu S, Wu W, Chen Q et al (2021) TXNRD1: a key regulator involved in the ferroptosis of CML cells induced by cysteine depletion in vitro. Oxid Med Cell Longev 2021:7674565. https:\/\/doi.org\/10.1155\/2021\/7674565","journal-title":"Oxid Med Cell Longev"},{"key":"2130_CR62","doi-asserted-by":"publisher","first-page":"153514","DOI":"10.1016\/j.tox.2023.153514","volume":"490","author":"J Ma","year":"2023","unstructured":"Ma J, Wang J, Ma C et al (2023) Wnt5a\/Ca(2+) signaling regulates silica-induced ferroptosis in mouse macrophages by altering ER stress-mediated redox balance. Toxicology 490:153514. https:\/\/doi.org\/10.1016\/j.tox.2023.153514","journal-title":"Toxicology"},{"key":"2130_CR63","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/ncb2432","volume":"14","author":"W Zhang","year":"2012","unstructured":"Zhang W, Trachootham D, Liu J et al (2012) Stromal control of cystine metabolism promotes cancer cell survival in chronic lymphocytic leukaemia. Nat Cell Biol 14:276\u2013286. https:\/\/doi.org\/10.1038\/ncb2432","journal-title":"Nat Cell Biol"},{"key":"2130_CR64","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/brain\/awu312","volume":"138","author":"P Mesci","year":"2015","unstructured":"Mesci P, Za\u00efdi S, Lobsiger CS et al (2015) System xC- is a mediator of microglial function and its deletion slows symptoms in amyotrophic lateral sclerosis mice. Brain 138:53\u201368. https:\/\/doi.org\/10.1093\/brain\/awu312","journal-title":"Brain"},{"key":"2130_CR65","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1016\/j.ymthe.2020.08.021","volume":"28","author":"J Liu","year":"2020","unstructured":"Liu J, Xia X, Huang P (2020) xCT: a critical molecule that links cancer metabolism to redox signaling. Mol Therapy J Am Soc Gene Therapy 28:2358\u20132366. https:\/\/doi.org\/10.1016\/j.ymthe.2020.08.021","journal-title":"Mol Therapy J Am Soc Gene Therapy"},{"key":"2130_CR66","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1038\/s41375-022-01573-6","volume":"36","author":"B Pardieu","year":"2022","unstructured":"Pardieu B, Pasanisi J, Ling F et al (2022) Cystine uptake Inhibition potentiates front-line therapies in acute myeloid leukemia. Leukemia 36:1585\u20131595. https:\/\/doi.org\/10.1038\/s41375-022-01573-6","journal-title":"Leukemia"},{"key":"2130_CR67","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.ymthe.2020.09.024","volume":"29","author":"Z Wang","year":"2021","unstructured":"Wang Z, Chen X, Liu N et al (2021) A nuclear long Non-Coding RNA LINC00618 accelerates ferroptosis in a manner dependent upon apoptosis. Mol Therapy J Am Soc Gene Therapy 29:263\u2013274. https:\/\/doi.org\/10.1016\/j.ymthe.2020.09.024","journal-title":"Mol Therapy J Am Soc Gene Therapy"},{"key":"2130_CR68","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1089\/dna.2022.0661","volume":"42","author":"N Liu","year":"2023","unstructured":"Liu N, Liu G, Jiang H, Yu J, Jin Y, Wang H (2023) Effect of the mitogen-activated protein kinase pathway on the erastin-induced ferroptosis of molt-4 cells. DNA Cell Biol 42:348\u2013356. https:\/\/doi.org\/10.1089\/dna.2022.0661","journal-title":"DNA Cell Biol"},{"key":"2130_CR69","doi-asserted-by":"publisher","first-page":"5989","DOI":"10.1182\/blood-2023-180676","volume":"142","author":"G Zhu","year":"2023","unstructured":"Zhu G, Fu W, Xu L et al (2023) Arsenic trioxide combine with G-CSF Triggers distinct TP53 mutations acute myeloid leukemia cells ferroptosis through TP53-SLC7A11-GPX4 pathway. Blood 142:5989. https:\/\/doi.org\/10.1182\/blood-2023-180676","journal-title":"Blood"},{"key":"2130_CR70","doi-asserted-by":"publisher","first-page":"177058","DOI":"10.1016\/j.ejphar.2024.177058","volume":"985","author":"G Yang","year":"2024","unstructured":"Yang G, Yang S, Li J et al (2024) Low-dose treatment with epirubicin, a novel histone deacetylase 1 inhibitor, exerts anti-leukemic effects by inducing ferroptosis. Eur J Pharmacol 985:177058. https:\/\/doi.org\/10.1016\/j.ejphar.2024.177058","journal-title":"Eur J Pharmacol"},{"key":"2130_CR71","doi-asserted-by":"publisher","first-page":"e041947c","DOI":"10.1097\/01.HS9.0000974064.04194.7c","volume":"7","author":"J LI","year":"2023","unstructured":"LI J, Luo L, Liu W, Hu J (2023) PB1804: SLC7A11 IS a potential therapeutic target in acute myeloid leukemia. HemaSphere 7:e041947c. https:\/\/doi.org\/10.1097\/01.HS9.0000974064.04194.7c","journal-title":"HemaSphere"},{"key":"2130_CR72","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1038\/s41467-020-15109-y","volume":"11","author":"J Cao","year":"2020","unstructured":"Cao J, Chen X, Jiang L et al (2020) DJ-1 suppresses ferroptosis through preserving the activity of S-adenosyl homocysteine hydrolase. Nat Commun 11:1251. https:\/\/doi.org\/10.1038\/s41467-020-15109-y","journal-title":"Nat Commun"},{"key":"2130_CR73","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/cdd.2015.93","volume":"23","author":"M Hayano","year":"2016","unstructured":"Hayano M, Yang WS, Corn CK, Pagano NC, Stockwell BR (2016) Loss of cysteinyl-tRNA synthetase (CARS) induces the transsulfuration pathway and inhibits ferroptosis induced by cystine deprivation. Cell Death Differ 23:270\u2013278. https:\/\/doi.org\/10.1038\/cdd.2015.93","journal-title":"Cell Death Differ"},{"key":"2130_CR74","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.cmet.2019.09.009","volume":"30","author":"J Zhu","year":"2019","unstructured":"Zhu J, Berisa M, Schw\u00f6rer S, Qin W, Cross JR, Thompson CB (2019) Transsulfuration activity can support cell growth upon extracellular cysteine limitation. Cell Metabol 30:865\u2013876e865. https:\/\/doi.org\/10.1016\/j.cmet.2019.09.009","journal-title":"Cell Metabol"},{"key":"2130_CR75","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1101\/gad.326470.119","volume":"33","author":"M Rashkovan","year":"2019","unstructured":"Rashkovan M, Ferrando A (2019) Metabolic dependencies and vulnerabilities in leukemia. Genes Dev 33:1460\u20131474. https:\/\/doi.org\/10.1101\/gad.326470.119","journal-title":"Genes Dev"},{"key":"2130_CR76","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/s0009-8981(99)00222-3","volume":"293","author":"GS Devi","year":"2000","unstructured":"Devi GS, Prasad MH, Saraswathi I, Raghu D, Rao DN, Reddy PP (2000) Free radicals antioxidant enzymes and lipid peroxidation in different types of leukemias. Clin Chim Acta 293:53\u201362. https:\/\/doi.org\/10.1016\/s0009-8981(99)00222-3","journal-title":"Clin Chim Acta"},{"key":"2130_CR77","first-page":"403","volume":"47","author":"VS Ghalaut","year":"1999","unstructured":"Ghalaut VS, Ghalaut PS, Singh S (1999) Lipid peroxidation in leukaemia. J Assoc Phys India 47:403\u2013405.","journal-title":"J Assoc Phys India"},{"key":"2130_CR78","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s40164-023-00427-w","volume":"12","author":"X Zheng","year":"2023","unstructured":"Zheng X, Jin X, Ye F et al (2023) Ferroptosis: a novel regulated cell death participating in cellular stress response, radiotherapy, and immunotherapy. Exp Hematol Oncol 12:65. https:\/\/doi.org\/10.1186\/s40164-023-00427-w","journal-title":"Exp Hematol Oncol"},{"key":"2130_CR79","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s43018-023-00653-5","volume":"5","author":"C Bruedigam","year":"2024","unstructured":"Bruedigam C, Porter AH, Song A et al (2024) Imetelstat-mediated alterations in fatty acid metabolism to induce ferroptosis as a therapeutic strategy for acute myeloid leukemia. Nat Cancer 5:47\u201365. https:\/\/doi.org\/10.1038\/s43018-023-00653-5","journal-title":"Nat Cancer"},{"key":"2130_CR80","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-024-02442-0","author":"F Nardi","year":"2024","unstructured":"Nardi F, Del Prete R, Drago R et al (2024) Apoliprotein E-mediated ferroptosis controls cellular proliferation in chronic lymphocytic leukemia. Leukemia 39:122\u2013133. https:\/\/doi.org\/10.1038\/s41375-024-02442-0","journal-title":"Leukemia"},{"key":"2130_CR81","first-page":"370","volume":"9","author":"JL Lai","year":"1995","unstructured":"Lai JL, Preudhomme C, Zandecki M et al (1995) Myelodysplastic syndromes and acute myeloid leukemia with 17p deletion. An entity characterized by specific dysgranulopo\u00efesis and a high incidence of P53 mutations. Leukemia 9:370\u2013381.","journal-title":"Leukemia"},{"key":"2130_CR82","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s40364-024-00579-9","volume":"12","author":"JE Zawacka","year":"2024","unstructured":"Zawacka JE (2024) p53 biology and reactivation for improved therapy in MDS and AML. Biomark Res 12:34. https:\/\/doi.org\/10.1186\/s40364-024-00579-9","journal-title":"Biomark Res"},{"key":"2130_CR83","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1038\/leu.2016.350","volume":"31","author":"A Quint\u00e1s-Cardama","year":"2017","unstructured":"Quint\u00e1s-Cardama A, Hu C, Qutub A et al (2017) p53 pathway dysfunction is highly prevalent in acute myeloid leukemia independent of TP53 mutational status. Leukemia 31:1296\u20131305. https:\/\/doi.org\/10.1038\/leu.2016.350","journal-title":"Leukemia"},{"key":"2130_CR84","doi-asserted-by":"publisher","first-page":"920273","DOI":"10.3389\/fgene.2022.920273","volume":"13","author":"J Hu","year":"2022","unstructured":"Hu J, Zhang R, Chang Q et al (2022) p53: A regulator of ferroptosis induced by galectin-1 derived peptide 3 in MH7A cells. Front Genet 13:920273. https:\/\/doi.org\/10.3389\/fgene.2022.920273","journal-title":"Front Genet"},{"key":"2130_CR85","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/s41418-022-00943-y","volume":"29","author":"Y Liu","year":"2022","unstructured":"Liu Y, Gu W (2022) p53 in ferroptosis regulation: the new weapon for the old guardian. Cell Death Differ 29:895\u2013910. https:\/\/doi.org\/10.1038\/s41418-022-00943-y","journal-title":"Cell Death Differ"},{"key":"2130_CR86","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1200\/jco.20.02342","volume":"39","author":"T Cluzeau","year":"2021","unstructured":"Cluzeau T, Sebert M, Rahm\u00e9 R et al (2021) Eprenetapopt plus azacitidine in TP53-mutated myelodysplastic syndromes and acute myeloid leukemia: a phase II study by the groupe Francophone des my\u00e9lodysplasies (GFM). J Clin Oncol Off J Am Soc Clin Oncol 39:1575\u20131583. https:\/\/doi.org\/10.1200\/jco.20.02342","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"2130_CR87","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1002\/tox.23126","volume":"36","author":"LH Dong","year":"2021","unstructured":"Dong LH, Huang JJ, Zu P et al (2021) CircKDM4C upregulates P53 by sponging hsa-let-7b-5p to induce ferroptosis in acute myeloid leukemia. Environ Toxicol 36:1288\u20131302. https:\/\/doi.org\/10.1002\/tox.23126","journal-title":"Environ Toxicol"},{"key":"2130_CR88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10428194.2016.1272682","volume":"58","author":"LF Peterson","year":"2017","unstructured":"Peterson LF, Lo MC, Liu Y et al (2017) Induction of p53 suppresses chronic myeloid leukemia. Leuk Lymphoma 58:1\u201314. https:\/\/doi.org\/10.1080\/10428194.2016.1272682","journal-title":"Leuk Lymphoma"},{"key":"2130_CR89","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/leu.2011.7","volume":"25","author":"LF Peterson","year":"2011","unstructured":"Peterson LF, Mitrikeska E, Giannola D et al (2011) p53 stabilization induces apoptosis in chronic myeloid leukemia blast crisis cells. Leukemia 25:761\u2013769. https:\/\/doi.org\/10.1038\/leu.2011.7","journal-title":"Leukemia"},{"key":"2130_CR90","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1182\/blood-2014-02-558833","volume":"124","author":"A Stengel","year":"2014","unstructured":"Stengel A, Schnittger S, Weissmann S et al (2014) TP53 mutations occur in 15.7% of ALL and are associated with MYC-rearrangement, low hypodiploidy, and a poor prognosis. Blood 124:251\u2013258. https:\/\/doi.org\/10.1182\/blood-2014-02-558833","journal-title":"Blood"},{"key":"2130_CR91","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.3109\/10428194.2011.654115","volume":"53","author":"L Sellmann","year":"2012","unstructured":"Sellmann L, Carpinteiro A, N\u00fcckel H et al (2012) p53 protein expression in chronic lymphocytic leukemia. Leuk Lymphoma 53:1282\u20131288. https:\/\/doi.org\/10.3109\/10428194.2011.654115","journal-title":"Leuk Lymphoma"},{"key":"2130_CR92","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21113928","author":"C Panuzzo","year":"2020","unstructured":"Panuzzo C, Jovanovski A, Pergolizzi B et al (2020) Mitochondria: s galaxy in the hematopoietic and leukemic stem cell universe. Int J Mol Sci 21:3928. https:\/\/doi.org\/10.3390\/ijms21113928","journal-title":"Int J Mol Sci"},{"key":"2130_CR93","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4103\/sjmms.sjmms_112_18","volume":"8","author":"E Al Ageeli","year":"2020","unstructured":"Al Ageeli E (2020) Alterations of mitochondria and related metabolic pathways in leukemia: a narrative review. Saudi J Med Med Sci 8:3\u201311. https:\/\/doi.org\/10.4103\/sjmms.sjmms_112_18","journal-title":"Saudi J Med Med Sci"},{"key":"2130_CR94","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.202105043","author":"B Gan","year":"2021","unstructured":"Gan B (2021) Mitochondrial regulation of ferroptosis. J Cell Biol 220:e202105043. https:\/\/doi.org\/10.1083\/jcb.202105043","journal-title":"J Cell Biol"},{"key":"2130_CR95","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1182\/blood-2021-148248","volume":"138","author":"H Akiyama","year":"2021","unstructured":"Akiyama H, Zhao R, Rahhal A et al (2021) Therapeutic targeting of ferroptosis pathway in combination with mitochondrial oxidative stress induction in acute myeloid leukemia. Blood 138:1162\u20131162. https:\/\/doi.org\/10.1182\/blood-2021-148248","journal-title":"Blood"},{"key":"2130_CR96","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/s41375-023-02117-2","volume":"38","author":"H Akiyama","year":"2024","unstructured":"Akiyama H, Zhao R, Ostermann LB et al (2024) Mitochondrial regulation of GPX4 inhibition-mediated ferroptosis in acute myeloid leukemia. Leukemia 38:729\u2013740. https:\/\/doi.org\/10.1038\/s41375-023-02117-2","journal-title":"Leukemia"},{"key":"2130_CR97","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40164-024-00489-4","volume":"13","author":"S Feng","year":"2024","unstructured":"Feng S, Yuan Y, Lin Z et al (2024) Low-dose hypomethylating agents cooperate with ferroptosis inducers to enhance ferroptosis by regulating the DNA methylation-mediated MAGEA6-AMPK-SLC7A11-GPX4 signaling pathway in acute myeloid leukemia. Exp Hematol Oncol 13:19. https:\/\/doi.org\/10.1186\/s40164-024-00489-4","journal-title":"Exp Hematol Oncol"},{"key":"2130_CR98","first-page":"730","volume":"9","author":"F Ye","year":"2019","unstructured":"Ye F, Chai W, Xie M et al (2019) HMGB1 regulates erastin-induced ferroptosis via RAS-JNK\/p38 signaling in HL-60\/NRAS(Q61L) cells. Am J cancer Res 9:730\u2013739.","journal-title":"Am J Cancer Res"},{"key":"2130_CR99","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s00432-024-05753-y","volume":"150","author":"H Zheng","year":"2024","unstructured":"Zheng H, Wu T, Lin Z et al (2024) Targeting BMAL1 reverses drug resistance of acute myeloid leukemia cells and promotes ferroptosis through HMGB1-GPX4 signaling pathway. J Cancer Res Clin Oncol 150:231. https:\/\/doi.org\/10.1007\/s00432-024-05753-y","journal-title":"J Cancer Res Clin Oncol"},{"key":"2130_CR100","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1007\/s43450-023-00502-7","volume":"34","author":"C Xu","year":"2024","unstructured":"Xu C, Chang W, Jiang H et al (2024) Calycosin induces ferroptosis by SLC7A11 through the PI3K\/Akt pathway in acute myelocytic leukemia. Rev Bras Farmacogn 34:776\u2013784. https:\/\/doi.org\/10.1007\/s43450-023-00502-7","journal-title":"Rev Bras Farmacogn"},{"key":"2130_CR101","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1007\/s11418-024-01811-4","volume":"78","author":"X Zhou","year":"2024","unstructured":"Zhou X, Zhang D, Lei J et al (2024) Polyphyllin I induces rapid ferroptosis in acute myeloid leukemia through simultaneous targeting PI3K\/SREBP-1\/SCD1 axis and triggering of lipid peroxidation. J Nat Med 78:618\u2013632. https:\/\/doi.org\/10.1007\/s11418-024-01811-4","journal-title":"J Nat Med"},{"key":"2130_CR102","doi-asserted-by":"publisher","first-page":"131","DOI":"10.14715\/cmb\/2023.69.7.21","volume":"69","author":"J Liu","year":"2023","unstructured":"Liu J, Gao W, Sheng Y, Sun J, Wen D (2023) Resveratrol drives ferroptosis of acute myeloid leukemia cells through Hsa-miR-335-5p\/NFS1\/ GPX4 pathway in a ROS-dependent manner. Cell Mol Biol (Noisy-le-Grand France) 69:131\u2013137. https:\/\/doi.org\/10.14715\/cmb\/2023.69.7.21","journal-title":"Cell Mol Biol (Noisy-le-Grand France)"},{"key":"2130_CR103","doi-asserted-by":"publisher","first-page":"181","DOI":"10.14715\/cmb\/2023.69.12.29","volume":"69","author":"G Zhao","year":"2023","unstructured":"Zhao G, Chen H, Luo J (2023) CircBCAR3 sponges miR-27a-3p and mediates ferroptosis in human B-prolymphocytic leukaemia cells via SLC7A11. Cell Mol Biol (Noisy-le-Grand France) 69:181\u2013187. https:\/\/doi.org\/10.14715\/cmb\/2023.69.12.29","journal-title":"Cell Mol Biol (Noisy-le-Grand France)"},{"key":"2130_CR104","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1097\/cm9.0000000000002642","volume":"136","author":"T Lyu","year":"2023","unstructured":"Lyu T, Li X, Song Y (2023) Ferroptosis in acute leukemia. Chin Med J 136:886\u2013898. https:\/\/doi.org\/10.1097\/cm9.0000000000002642","journal-title":"Chin Med J"},{"key":"2130_CR105","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.ejca.2017.09.016","volume":"86","author":"SK Metzelder","year":"2017","unstructured":"Metzelder SK, Schroeder T, L\u00fcbbert M et al (2017) Long-term survival of sorafenib-treated FLT3-ITD-positive acute myeloid leukaemia patients relapsing after allogeneic stem cell transplantation. Eur J Cancer (Oxford, England: 1990) 86:233\u2013239. https:\/\/doi.org\/10.1016\/j.ejca.2017.09.016","journal-title":"Eur J Cancer (Oxford, England: 1990)"},{"key":"2130_CR106","doi-asserted-by":"publisher","first-page":"5429","DOI":"10.2147\/ott.S254995","volume":"13","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Li Y, Zhang R, Wang F, Wang T, Jiao Y (2020) The role of erastin in ferroptosis and its prospects in cancer therapy. OncoTarg Therapy 13:5429\u20135441. https:\/\/doi.org\/10.2147\/ott.S254995","journal-title":"OncoTarg Therapy"},{"key":"2130_CR107","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1038\/s41417-022-00497-8","volume":"29","author":"X Wang","year":"2022","unstructured":"Wang X, Liu X, Wang H (2022) Combination regimen of granulocyte colony-stimulating factor and recombinant human thrombopoietin improves the curative effect on elderly patients with leukemia through inducing pyroptosis and ferroptosis of leukemia cells. Cancer Gene Ther 29:1742\u20131750. https:\/\/doi.org\/10.1038\/s41417-022-00497-8","journal-title":"Cancer Gene Ther"},{"key":"2130_CR108","doi-asserted-by":"publisher","first-page":"3334","DOI":"10.1021\/acsnano.2c06313","volume":"17","author":"Y Yu","year":"2023","unstructured":"Yu Y, Meng Y, Xu X et al (2023) A ferroptosis-inducing and leukemic cell-targeting drug nanocarrier formed by redox-responsive cysteine polymer for acute myeloid leukemia therapy. ACS Nano 17:3334\u20133345. https:\/\/doi.org\/10.1021\/acsnano.2c06313","journal-title":"ACS Nano"},{"key":"2130_CR109","doi-asserted-by":"publisher","first-page":"144889","DOI":"10.1016\/j.gene.2020.144889","volume":"755","author":"Y Du","year":"2020","unstructured":"Du Y, Bao J, Zhang MJ et al (2020) Targeting ferroptosis contributes to ATPR-induced AML differentiation via ROS-autophagy-lysosomal pathway. Gene 755:144889. https:\/\/doi.org\/10.1016\/j.gene.2020.144889","journal-title":"Gene"},{"key":"2130_CR110","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1002\/ddr.21983","volume":"83","author":"H Ma","year":"2022","unstructured":"Ma H, Liu Y, Miao Z et al (2022) Neratinib inhibits proliferation and promotes apoptosis of acute myeloid leukemia cells by activating autophagy-dependent ferroptosis. Drug Dev Res 83:1641\u20131653. https:\/\/doi.org\/10.1002\/ddr.21983","journal-title":"Drug Dev Res"},{"key":"2130_CR111","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/s41420-024-02148-3","volume":"10","author":"I Dias","year":"2024","unstructured":"Dias I, Costa RGA, Rodrigues A et al (2024) Bithionol eliminates acute myeloid leukaemia stem-like cells by suppressing NF-\u03baB signalling and inducing oxidative stress, leading to apoptosis and ferroptosis. Cell Death Discov 10:390. https:\/\/doi.org\/10.1038\/s41420-024-02148-3","journal-title":"Cell Death Discov"},{"key":"2130_CR112","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.actbio.2022.03.030","volume":"144","author":"Q Li","year":"2022","unstructured":"Li Q, Su R, Bao X et al (2022) Glycyrrhetinic acid nanoparticles combined with ferrotherapy for improved cancer immunotherapy. Acta Biomater 144:109\u2013120. https:\/\/doi.org\/10.1016\/j.actbio.2022.03.030","journal-title":"Acta Biomater"},{"key":"2130_CR113","doi-asserted-by":"publisher","first-page":"113662","DOI":"10.1016\/j.biopha.2022.113662","volume":"154","author":"E Catanzaro","year":"2022","unstructured":"Catanzaro E, Turrini E, Kerre T et al (2022) Perillaldehyde is a new ferroptosis inducer with a relevant clinical potential for acute myeloid leukemia therapy. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 154:113662. https:\/\/doi.org\/10.1016\/j.biopha.2022.113662","journal-title":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie"},{"key":"2130_CR114","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.bbrc.2019.06.070","volume":"516","author":"HY Zhu","year":"2019","unstructured":"Zhu HY, Huang ZX, Chen GQ, Sheng F, Zheng YS (2019) Typhaneoside prevents acute myeloid leukemia (AML) through suppressing proliferation and inducing ferroptosis associated with autophagy. Biochem Biophys Res Commun 516:1265\u20131271. https:\/\/doi.org\/10.1016\/j.bbrc.2019.06.070","journal-title":"Biochem Biophys Res Commun"},{"key":"2130_CR115","doi-asserted-by":"publisher","first-page":"4511","DOI":"10.1007\/s00277-024-06003-4","volume":"103","author":"P Han","year":"2024","unstructured":"Han P, Wei S, Wang H, Cai Y (2024) Licochalcone A decreases cancer cell proliferation and enhances ferroptosis in acute myeloid leukemia through suppressing the IGF2BP3\/MDM2 cascade. Ann Hematol 103:4511\u20134524. https:\/\/doi.org\/10.1007\/s00277-024-06003-4","journal-title":"Ann Hematol"},{"key":"2130_CR116","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtemb.2024.127517","author":"M Wu","year":"2024","unstructured":"Wu M, Li A, Zhang T et al (2024) The novel prognostic analysis of AML based on ferroptosis and cuproptosis related genes. J Trace Elem Med Biol Organ Soc Minerals Trace Elem (GMS) 86:127517. https:\/\/doi.org\/10.1016\/j.jtemb.2024.127517","journal-title":"J Trace Elem Med Biol Organ Soc Miner Trace Elem (GMS)"},{"key":"2130_CR117","doi-asserted-by":"publisher","first-page":"1275774","DOI":"10.3389\/fmolb.2023.1275774","volume":"10","author":"H Zhang","year":"2023","unstructured":"Zhang H, Sun C, Sun Q, Li Y, Zhou C, Sun C (2023) Susceptibility of acute myeloid leukemia cells to ferroptosis and evasion strategies. Front Mol Biosci 10:1275774. https:\/\/doi.org\/10.3389\/fmolb.2023.1275774","journal-title":"Front Mol Biosci"},{"key":"2130_CR118","doi-asserted-by":"publisher","first-page":"748925","DOI":"10.3389\/fcell.2021.748925","volume":"9","author":"ZZ Shi","year":"2021","unstructured":"Shi ZZ, Tao H, Fan ZW, Song SJ, Bai J (2021) Prognostic and immunological role of key genes of ferroptosis in pan-cancer. Front Cell Dev Biol 9:748925. https:\/\/doi.org\/10.3389\/fcell.2021.748925","journal-title":"Front Cell Dev Biol"},{"key":"2130_CR119","doi-asserted-by":"publisher","first-page":"930654","DOI":"10.3389\/fonc.2022.930654","volume":"12","author":"Z Zheng","year":"2022","unstructured":"Zheng Z, Hong X, Huang X et al (2022) Comprehensive analysis of ferroptosis-related gene signatures as a potential therapeutic target for acute myeloid leukemia: a bioinformatics analysis and experimental verification. Front Oncol 12:930654. https:\/\/doi.org\/10.3389\/fonc.2022.930654","journal-title":"Front Oncol"},{"key":"2130_CR120","doi-asserted-by":"publisher","first-page":"1207642","DOI":"10.3389\/fcell.2023.1207642","volume":"11","author":"D Fu","year":"2023","unstructured":"Fu D, Zhang B, Wu S, Feng J, Jiang H (2023) Molecular subtyping of acute myeloid leukemia through ferroptosis signatures predicts prognosis and deciphers the immune microenvironment. Front Cell Dev Biol 11:1207642. https:\/\/doi.org\/10.3389\/fcell.2023.1207642","journal-title":"Front Cell Dev Biol"},{"key":"2130_CR121","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1111\/ijlh.14319","volume":"46","author":"XS Yan","year":"2024","unstructured":"Yan XS, Sun YJ, Du J, Niu WY, Qiao H, Yin XC (2024) Effects of ferroptosis-related gene HSPB1 on acute myeloid leukemia. Int J Lab Hematol 46:899\u2013909. https:\/\/doi.org\/10.1111\/ijlh.14319","journal-title":"Int J Lab Hematol"},{"key":"2130_CR122","doi-asserted-by":"publisher","first-page":"382","DOI":"10.3324\/haematol.2022.280786","volume":"108","author":"ME Lalonde","year":"2023","unstructured":"Lalonde ME, Sasseville M, G\u00e9linas AM et al (2023) Genome-wide CRISPR screens identify ferroptosis as a novel therapeutic vulnerability in acute lymphoblastic leukemia. Haematologica 108:382\u2013393. https:\/\/doi.org\/10.3324\/haematol.2022.280786","journal-title":"Haematologica"},{"key":"2130_CR123","doi-asserted-by":"publisher","first-page":"1402669","DOI":"10.3389\/fimmu.2024.1402669","volume":"15","author":"F Zhong","year":"2024","unstructured":"Zhong F, Zhang X, Wang Z et al (2024) The therapeutic and biomarker significance of ferroptosis in chronic myeloid leukemia. Front Immunol 15:1402669. https:\/\/doi.org\/10.3389\/fimmu.2024.1402669","journal-title":"Front Immunol"},{"key":"2130_CR124","doi-asserted-by":"publisher","first-page":"800267","DOI":"10.3389\/fcell.2021.800267","volume":"9","author":"J Wang","year":"2021","unstructured":"Wang J, Zhuo Z, Wang Y et al (2021) Identification and validation of a prognostic risk-scoring model based on ferroptosis-associated cluster in acute myeloid leukemia. Front Cell Dev Biol 9:800267. https:\/\/doi.org\/10.3389\/fcell.2021.800267","journal-title":"Front Cell Dev Biol"},{"key":"2130_CR125","doi-asserted-by":"publisher","first-page":"608","DOI":"10.17305\/bjbms.2021.6274","volume":"22","author":"X Huang","year":"2022","unstructured":"Huang X, Zhou D, Ye X, Jin J (2022) A novel ferroptosis-related gene signature can predict prognosis and influence immune microenvironment in acute myeloid leukemia. Bosnian J Basic Med Sci 22:608\u2013628. https:\/\/doi.org\/10.17305\/bjbms.2021.6274","journal-title":"Bosnian J Basic Med Sci"},{"key":"2130_CR126","doi-asserted-by":"publisher","first-page":"916","DOI":"10.29271\/jcpsp.2024.08.916","volume":"34","author":"J Zhao","year":"2024","unstructured":"Zhao J, Guan J, Zhang X, Jiang J, Dou K (2024) Genetic analysis of potential biomarkers and therapeutic targets in ferroptosis from steroid-induced osteonecrosis of the femoral head based on machine learning. J Coll Phys Surg Pak JCPSP 34:916\u2013921. https:\/\/doi.org\/10.29271\/jcpsp.2024.08.916","journal-title":"J Coll Phys Surg Pak JCPSP"},{"key":"2130_CR127","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.7150\/ijbs.45050","volume":"16","author":"JY Liang","year":"2020","unstructured":"Liang JY, Wang DS, Lin HC et al (2020) A novel ferroptosis-related gene signature for overall survival prediction in patients with hepatocellular carcinoma. Int J Biol Sci 16:2430\u20132441. https:\/\/doi.org\/10.7150\/ijbs.45050","journal-title":"Int J Biol Sci"},{"key":"2130_CR128","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1182\/blood-2019-131055","volume":"134","author":"DA Sallman","year":"2019","unstructured":"Sallman DA, DeZern AE, Garcia-Manero G et al (2019) Phase 2 results of APR-246 and Azacitidine (AZA) in patients with TP53 mutant myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia (AML). Blood 134:676\u2013676. https:\/\/doi.org\/10.1182\/blood-2019-131055","journal-title":"Blood"},{"key":"2130_CR129","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1182\/blood-2019-125579","volume":"134","author":"T Cluzeau","year":"2019","unstructured":"Cluzeau T, Sebert M, Rahm\u00e9 R et al (2019) APR-246 combined with Azacitidine (AZA) in TP53 mutated myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). A phase 2 study by the groupe Francophone des my\u00e9lodysplasies (GFM). Blood 134:677\u2013677. https:\/\/doi.org\/10.1182\/blood-2019-125579","journal-title":"Blood"},{"key":"2130_CR130","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s13046-023-02712-2","volume":"42","author":"T Zheng","year":"2023","unstructured":"Zheng T, Liu Q, Xing F, Zeng C, Wang W (2023) Disulfidptosis: a new form of programmed cell death. J Exp Clin Cancer Res CR 42:137. https:\/\/doi.org\/10.1186\/s13046-023-02712-2","journal-title":"J Exp Clin Cancer Res CR"},{"key":"2130_CR131","doi-asserted-by":"publisher","first-page":"114830","DOI":"10.1016\/j.biopha.2023.114830","volume":"163","author":"D Wang","year":"2023","unstructured":"Wang D, Tian Z, Zhang P et al (2023) The molecular mechanisms of cuproptosis and its relevance to cardiovascular disease. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 163:114830. https:\/\/doi.org\/10.1016\/j.biopha.2023.114830","journal-title":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie"}],"container-title":["Apoptosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-025-02130-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10495-025-02130-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-025-02130-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T14:21:17Z","timestamp":1752675677000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10495-025-02130-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,9]]},"references-count":131,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["2130"],"URL":"https:\/\/doi.org\/10.1007\/s10495-025-02130-z","relation":{},"ISSN":["1360-8185","1573-675X"],"issn-type":[{"value":"1360-8185","type":"print"},{"value":"1573-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,9]]},"assertion":[{"value":"25 May 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}